GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Origin Therapeutics Holdings Inc (XCNQ:ORIG) » Definitions » ROE % Adjusted to Book Value

Origin Therapeutics Holdings (XCNQ:ORIG) ROE % Adjusted to Book Value : -17.87% (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings ROE % Adjusted to Book Value?

Origin Therapeutics Holdings's ROE % for the quarter that ended in Jun. 2023 was -8.22%. Origin Therapeutics Holdings's PB Ratio for the quarter that ended in Jun. 2023 was 0.46. Origin Therapeutics Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was -17.87%.


Origin Therapeutics Holdings ROE % Adjusted to Book Value Historical Data

The historical data trend for Origin Therapeutics Holdings's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings ROE % Adjusted to Book Value Chart

Origin Therapeutics Holdings Annual Data
Trend Sep21 Sep22
ROE % Adjusted to Book Value
- -50.13

Origin Therapeutics Holdings Quarterly Data
Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only -30.62 -82.06 -46.14 -453.49 -17.87

Competitive Comparison of Origin Therapeutics Holdings's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Origin Therapeutics Holdings's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's ROE % Adjusted to Book Value falls into.



Origin Therapeutics Holdings ROE % Adjusted to Book Value Calculation

Origin Therapeutics Holdings's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2022 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-23.56% / 0.47
=-50.13%

Origin Therapeutics Holdings's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-8.22% / 0.46
=-17.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Origin Therapeutics Holdings ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Origin Therapeutics Holdings (XCNQ:ORIG) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
505 Burrard Street, Suite 1570, Vancouver, BC, CAN, V7X 1M5
Origin Therapeutics Holdings Inc is an investment company focusing on investments in the psychedelic industry.

Origin Therapeutics Holdings (XCNQ:ORIG) Headlines